SMPD1 and migraine disorder: In this sense, FIASMA (Functional Inhibitor of Acid SphingoMyelinAse), a family of drugs with inhibitory effects on aSMase activity, and some of them approved for clinical use as antidepressants for use in humans [79], should be addressed for therapeutic use in migraine.